Skip to main content
. 2020 Apr 6;10:5971. doi: 10.1038/s41598-020-62912-0

Figure 5.

Figure 5

Clinicopathological relevance of CXXC5 expressions in breast cancer patients. (a) CXXC5 expression in breast cancer (BC) as compared to normal breast tissue from METABRIC. (b) CXXC5 expression in ER-negative versus ER-positive breast cancer patients from METABRIC. (c) CXXC5 expression in different molecular subtypes of tumors of breast cancer patients from METABRIC. (d) Pearson correlation analysis between mRNA expressions of CXXC5 and ESR1 (ERα) in patients from METABRIC. (e) Pearson correlation analysis between mRNA expression of CXXC5 and ERα protein level in breast cancer patients from TCGA. (f) Kaplan Meier survival analysis of basal breast cancer patients based on CXXC5 expression separated from the median.